Company Update (NYSE:JNJ): Johnson & Johnson Announces Agreement To Acquire Novira Therapeutics, Inc.

[PR Newswire] – NEW BRUNSWICK, N.J., Nov. 4, 2015 /PRNewswire/ — Johnson & Johnson (JNJ) today announced a definitive agreement to acquire Novira Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company developing novel . . . → Read More: Company Update (NYSE:JNJ): Johnson & Johnson Announces Agreement To Acquire Novira Therapeutics, Inc. Similar Articles: Company Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2015 Stock Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson Consumer Inc. Announces Completion of the Divestiture of SPLENDA® Brand to Heartland Food Products Group Market Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson Announces Acceptance of Binding Offer From Cardinal Health To Acquire Cordis